共 245 条
[1]
Lehtinen M(2007)Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions N Engl J Med 356 1915-27
[2]
Paavonen J(2012)Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial Lancet Oncol. 13 89-99
[3]
Wheeler CM(2015)Human papilloma virus vaccination: impact and recommendations across the world Ther Adv Vaccines. 3 3-12
[4]
Jaisamrarn U(2011)Prevention of cervical cancer in rural China: evaluation of HPV vaccination and primary HPV screening strategies Vaccine 29 2487-94
[5]
Garland SM(2014)The human papillomavirus vaccination: a review of the cost-effectiveness studies Clin Ter 165 e426-32
[6]
Castellsagué X(2009)Human papillomavirus vaccines, WHO position paper Wkly Epidemiol Rec 84 118-31
[7]
Bonanni P(2011)A generally applicable cost- effectiveness model for the evaluation of vaccines against cervical cancer Int J Public Health. 56 153-62
[8]
Bechini A(2007)Cost-effectiveness analyses of human papillomavirus vaccination Lancet Infect Dis. 7 289-96
[9]
Donato R(2008)Cost-effectiveness of HPV vaccination compared with Pap smear screening on a national scale: a literature review Vaccine. 26 6258-65
[10]
Capei R(2009)Effectiveness and cost effectiveness of human papillomavirus vaccine: a systematic review Pharmacoeconomics. 27 127-47